TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+5.43%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$3.11B
AUM Growth
+$3.11B
(+0.07%)
Cap. Flow
-$18.4M
Cap. Flow
% of AUM
-0.59%
Top 10 Holdings %
Top 10 Hldgs %
35.29%
Holding
188
New
16
Increased
27
Reduced
40
Closed
17
Top Buys
| 1 |
Pfizer
PFE
|
$42.6M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$29.7M |
| 3 |
Moderna
MRNA
|
$22.1M |
| 4 |
Danaher
DHR
|
$17.7M |
| 5 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$16.4M |
Top Sells
| 1 |
Biogen
BIIB
|
$23.6M |
| 2 |
Exact Sciences
EXAS
|
$21.5M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
$19.2M |
| 4 |
Cigna
CI
|
$18M |
| 5 |
Dentsply Sirona
XRAY
|
$17.3M |
Sector Composition
| 1 | Healthcare | 96.33% |
| 2 | Real Estate | 2.82% |
| 3 | Industrials | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Cigna
CI
$80.3B
| $32.9M | 1.06% | 143,423 -78,317 | -35% | -$18M |
|
|
27
Biogen
BIIB
$19.4B
| $32.5M | 1.05% | 135,639 -98,214 | -42% | -$23.6M |
|
28
Humana
HUM
$36.5B
| $32.3M | 1.04% | 69,660 +16,525 | +31% | +$7.67M |
|
29
Alnylam Pharmaceuticals
ALNY
$58.5B
| $32.2M | 1.04% | 189,695 | – | – |
|
30
Molina Healthcare
MOH
$9.8B
| $31.3M | 1.01% | 98,325 +14,700 | +18% | +$4.68M |
|
31
Icon
ICLR
$13.8B
| $30.6M | 0.99% | 98,871 | – | – |
|
32
Zoetis
ZTS
$69.3B
| $29.9M | 0.96% | 122,497 -20,100 | -14% | -$4.91M |
|
33
HCA Healthcare
HCA
$94.5B
| $28.8M | 0.93% | 111,961 | – | – |
|
34
Sarepta Therapeutics
SRPT
$1.78B
| $28.4M | 0.92% | 315,897 -110,617 | -26% | -$9.96M |
|
35
IQVIA
IQV
$32.4B
| $27.7M | 0.89% | 98,154 +21,510 | +28% | +$6.07M |
|
36
Charles River Laboratories
CRL
$8.04B
| $23.4M | 0.75% | 61,990 -16,494 | -21% | -$6.21M |
|
37
BioNTech
BNTX
$24B
| $23.3M | 0.75% | 90,242 +9,485 | +12% | +$2.45M |
|
38
Edwards Lifesciences
EW
$47.8B
| $23M | 0.74% | 177,188 -17,442 | -9% | -$2.26M |
|
39
Boston Scientific
BSX
$156B
| $22.8M | 0.73% | 536,042 +350,111 | +188% | +$14.9M |
|
40
DexCom
DXCM
$29.5B
| $22.5M | 0.72% | 41,931 -1,049 | -2% | -$563K |
|
41
United Therapeutics
UTHR
$13.8B
| $22M | 0.71% | 101,737 -43,203 | -30% | -$9.34M |
|
42
Intuitive Surgical
ISRG
$170B
| $20.7M | 0.67% | 57,606 +37,604 | +188% | +$13.5M |
|
43
Rallybio
RLYB
$22.4M
| $20.4M | 0.66% | 2,308,670 -2 | -0% | -$18 |
|
44
ResMed
RMD
$40.2B
| $19.4M | 0.63% | 74,599 +60,410 | +426% | +$15.7M |
|
45
Zimmer Biomet
ZBH
$21B
| $18M | 0.58% | 142,044 -80,659 | -36% | -$10.2M |
|
46
Welltower
WELL
$113B
| $17.4M | 0.56% | 203,083 | – | – |
|
|
ONC
47
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $17.3M | 0.56% | 63,772 | – | – |
|
|
ARNA
48
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $16.4M | 0.53% | 175,976 +92,347 | +110% | +$8.58M |
|
49
Health Care Select Sector SPDR Fund
XLV
$33.9B
| $16M | 0.51% | 113,230 -19,600 | -15% | -$2.76M |
|
50
CVS Health
CVS
$92.8B
| $15.2M | 0.49% | 147,453 | – | – |
|